NBGV — Newbridge Global Ventures Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $4.19m
- $0.03m
Annual income statement for Newbridge Global Ventures, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2014 June 30th | 2015 June 30th | R2016 December 31st | 2017 December 31st | 2018 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0.027 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2.66 | 0.804 | 1.4 | 2.12 | -1.28 |
Operating Profit | -2.66 | -0.804 | -1.4 | -2.12 | 1.31 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.74 | -0.823 | -1.4 | -2.26 | -3.35 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.74 | -0.823 | -1.4 | -2.26 | -3.35 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -3.5 | -0.823 | -4.04 | -4.2 | -3.35 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.5 | -0.823 | -4.04 | -4.2 | -3.35 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -128 | -8.39 | -2.05 | -1.16 | -0.287 |